TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.78+0.02 (+2.36%)
Close on Nov 18, 2026Market cap $35.02MP/E –Yield –
TELA Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
TELA Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$31.14M. For fiscal 2025 it was -$28.22M. The highest annual figure on record is -$16.37M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$28.22M | – |
| FY2024 | Dec 31, 2024 | -$41.60M | – |
| FY2023 | Dec 31, 2023 | -$40.86M | – |
| FY2022 | Dec 31, 2022 | -$40.75M | – |
| FY2021 | Dec 31, 2021 | -$30.43M | – |
| FY2020 | Dec 31, 2020 | -$24.46M | – |
| FY2019 | Dec 31, 2019 | -$25.52M | – |
| FY2018 | Dec 31, 2018 | -$19.92M | – |
| FY2017 | Dec 31, 2017 | -$16.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.38M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.87M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.72M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.91M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.73M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.53M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.98M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.70M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.38M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.97M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.26M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.57M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.65M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.69M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.43M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.59M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.63M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.63M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.59M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.10M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.69M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.36M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.31M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.21M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.78M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.76M | – |
See a number that looks wrong?